# United States Gasoline Fund, LP: financial statements, quarterly

UGA · NYSE · CIK 1396878 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/uga.md) · [Financials](/companies/uga/financials.md) · [Filings](/companies/uga/filings.md) · [Insiders](/companies/uga/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/uga/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5.5](/filings/0001410578-25-000238.md) | [(8.2)](/filings/0001410578-25-000238.md) | [16.1](/filings/0001104659-26-021515.md) | [(3.5)](/filings/0001104659-26-021515.md) | [(13.5)](/filings/0001104659-26-021515.md) | [7.5](/filings/0001104659-26-021515.md) | [2.3](/filings/0001104659-26-057773.md) | [(5.5)](/filings/0001104659-26-092629.md) | [5.1](/filings/0001104659-26-021515.md) | [(5.0)](/filings/0001104659-26-021515.md) | [58.5](/filings/0001104659-26-057773.md) | [(2.0)](/filings/0001104659-26-092629.md) |
| Net income | $m | [5.3](/filings/0001410578-25-000238.md) | [(8.4)](/filings/0001410578-25-000238.md) | [15.9](/filings/0001104659-26-021515.md) | [(3.8)](/filings/0001104659-26-021515.md) | [(13.7)](/filings/0001104659-26-021515.md) | [7.2](/filings/0001104659-26-021515.md) | [2.1](/filings/0001104659-26-057773.md) | [(5.7)](/filings/0001104659-26-092629.md) | [4.9](/filings/0001104659-26-021515.md) | [(5.2)](/filings/0001104659-26-021515.md) | [58.2](/filings/0001104659-26-057773.md) | [(2.3)](/filings/0001104659-26-092629.md) |

- Revenue: us-gaap:Revenues
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [40.1](/filings/0001410578-24-001826.md) | [45.8](/filings/0001104659-26-021515.md) | [89.4](/filings/0001410578-25-001160.md) | [80.0](/filings/0001410578-25-001641.md) | [74.7](/filings/0001104659-25-108412.md) | [75.9](/filings/0001104659-26-021515.md) | [65.1](/filings/0001104659-26-057773.md) | [58.8](/filings/0001104659-26-092629.md) | [60.2](/filings/0001104659-25-108412.md) | [67.1](/filings/0001104659-26-092629.md) | [121](/filings/0001104659-26-057773.md) | [82.4](/filings/0001104659-26-092629.md) |
| Total assets | $m | [77.9](/filings/0001410578-23-002212.md) | [85.2](/filings/0001410578-25-000238.md) | [121](/filings/0001410578-24-000690.md) | [105](/filings/0001410578-24-001236.md) | [96.7](/filings/0001410578-24-001826.md) | [101](/filings/0001104659-26-021515.md) | [90.2](/filings/0001410578-25-001160.md) | [72.5](/filings/0001410578-25-001641.md) | [74.1](/filings/0001104659-25-108412.md) | [77.5](/filings/0001104659-26-092629.md) | [150](/filings/0001104659-26-057773.md) | [108](/filings/0001104659-26-092629.md) |
| Total liabilities | $m | [0.3](/filings/0001410578-23-002212.md) | [0.3](/filings/0001410578-25-000238.md) | [0.2](/filings/0001410578-24-000690.md) | [0.1](/filings/0001410578-24-001236.md) | [0.2](/filings/0001410578-24-001826.md) | [0.3](/filings/0001104659-26-021515.md) | [0.2](/filings/0001410578-25-001160.md) | [0.1](/filings/0001410578-25-001641.md) | [0.2](/filings/0001104659-25-108412.md) | [0.2](/filings/0001104659-26-092629.md) | [0.2](/filings/0001104659-26-057773.md) | [0.2](/filings/0001104659-26-092629.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [11.9 d](/filings/0001410578-24-001826.md) | [(14.6) d](/filings/0001104659-26-021515.md) | [12.8](/filings/0001410578-25-001160.md) | [(7.3) d](/filings/0001410578-25-001641.md) | [(8.6) d](/filings/0001104659-25-108412.md) | [4.3 d](/filings/0001104659-26-021515.md) | [0.6](/filings/0001104659-26-057773.md) | [3.2 d](/filings/0001104659-26-092629.md) | [2.5 d](/filings/0001104659-25-108412.md) | [(8.0) d](/filings/0001104659-26-021515.md) | [53.3](/filings/0001104659-26-057773.md) | [0.2 d](/filings/0001104659-26-092629.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 1,250,000 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092629.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.